Patch tests are used to confirm the diagnosis and investigate the etiology of allergic contact dermatitis (ACD).

A retrospective study was carried out at the Allergy and Phototherapy Sector of the Dermatology Clinic of Santa Casa de São Paulo, in the period from January 2006 to December 2011, with 618 patients with diagnostic hypothesis of ACD. The patients underwent the standard epicutaneous patch series recommended by the Brazilian Contact Dermatitis Research Group (Grupo Brasileiro de Estudos em Dermatite de Contato - GBEDC).^[@r01]^

The objective of the study was to evaluate the frequency variation of positive test results for substances present in the mentioned standard series, year by year, during the period studied.

The epicutaneous tests, manufactured by FDA Allergenic (Rio de Janeiro, Brazil) were applied to the back of the patients by means of FINN Chambers pads (Epitest Ltd, Oy, Finland). The reading was done 96 hours after application in order to avoid doubts about sensitization, as positive tests with intensity marked by two or three crosses were considered. The statistical analysis of data was done using the correlation test of Pearson (CP), considering data with p\<0.05 as having statistical significance.

There was predominance of the female gender in all of the studied years, totalling 195 men and 423 women. The predominant age group was the 30-49 years and 170 positive tests (17.6%) were related to the professions of the patients.

The main ACD sites were the cephalic segment (45.3%), followed by upper limbs (39%), hands (35.6%), lower limbs (28.64%), feet (20.71%) and torso (15.86%).

The total number of positive tests every year varied from 90 to 220, totaling 966 in the studied period. The positive test/patient variation was between 0.98 and 2.47 during the analyzed years.

The substances that presented higher positivity were: nickel sulphate (28.16%), thimerosal (16.02%), potassium dichromate (11.17%), cobalt chloride (10.52%), fragrance mix (8.74%), carba mix (7.28%), neomycin (7.28%), paraphenylenediamin (6.96%), PPD-mix (6.63%) and thiuram-mix (6.15%). The remaining substances were positive in less than 5% of cases ([Table 1](#t01){ref-type="table"}).

###### 

Sensitization rate of standard series substances - 618 patients - 2006-2011

  ------------------------- -------------------------- -------
  **Substance**             **Total positive tests**   **%**
  Nickel sulphate           174                        28.16
  Thimerosal                99                         16.02
  Potassium dichromate      69                         11.17
  Cobalt Chloride           65                         10.52
  Fragrance mix             54                         8.74
  Carba mix                 45                         7.28
  Neomycin                  45                         7.28
  Paraphenylenediamin       43                         6.96
  PPD mix                   41                         6.63
  Thiuram mix               38                         6.15
  Ethylenediamine           27                         4.37
  Promethazine              21                         3.40
  Formaldehyde              20                         3.24
  Mercaptobenzothiazole     20                         3.24
  Balsam of Peru            20                         3.24
  Parabens                  19                         3.07
  Hydroquinone              19                         3.07
  Colophony                 17                         2.75
  Lanolin                   16                         2.59
  Quaternium 15             16                         2.59
  Kathon CG                 15                         2.43
  Benzocaine                15                         2.43
  Nitrofurazone             14                         2.27
  Turpentine                11                         1.78
  Quinoline mix             10                         1.62
  Propylene glycol          10                         1.62
  Epoxi resin               9                          1.46
  P-tertiary Buthylphenol   5                          0.81
  Irgasan                   5                          0.81
  Anthraquinone             4                          0.65
  ------------------------- -------------------------- -------

Studies carried out in other communities and already published have shown that the main sensitizers were the same obtained in this investigation.^[@r01]-[@r06]^ Nevertheless, differences were observed in the sensitization rates for some of the substances tested. The nickel sulphate sensitization rate, for example, was 28.16% and frequency varied between 10.4% and 19%,^[@r07]-[@r10]^ in European and American publications. In several communities there are regulations regarding the limit of nickel release from items that may get into prolonged and direct contact with the skin, which contributed to the low sensitization rates.

Thimerosal, despite having been removed from several topical preparations, had a higher sensitization rate than that referred in other studies.^[@r02]-[@r06]^ This is due to its presence in preparations like vaccines, contact lenses solutions and tattoo ink, which favors the contact of the population with this substance.

The other sensitizers presented similar frequencies to those observed in other publications.^[@r01]-[@r06]^

[Table 2](#t02){ref-type="table"} shows the variation, year by year, of standard series substance positivity. Some substances presented similar frequencies for the entire period studied, while others varied every year. Most of the substances presented a discrete tendency for the number of positive tests to decrease along the period. Three substances presented a diminished statistically significant sensitization rate: Lanolin (p=0.01), Neomycin (p=0.01), Anthraquinone (p=0.04).

###### 

Sensitization rate of standard series substances per year - from 2006 to 2011

  ------------------------- ----------------- ------------------ ------------------ ------------------ ----------------- ----------------- ------------------- ----------------------------
                            **2006 (n=89)**   **2007 (n=100)**   **2008 (n=113)**   **2009 (n=126)**   **2010 (n=98)**   **2011 (n=92)**   **TOTAL (n=618)**   **Pearson\'s correlation**
  Nickel Sulphate           24                27                 34                 43                 23                24                175                 -0.1 (p=0.8)
  Thimerosal                25                6                  17                 22                 18                11                99                  -0.3 (p=0.5)
  Potassium Dichromate      19                13                 7                  14                 10                6                 69                  -0.7 (p=0.1)
  Cobalt Chloride           15                5                  10                 14                 11                11                66                  -0.1 (p=0.8)
  Fragrance mix             6                 2                  13                 10                 7                 8                 56                  0.4 (p=0.3)
  Carba mix                 18                5                  5                  7                  6                 5                 46                  -0.6 (p=0.1)
  Neomycin                  14                12                 6                  8                  5                 0                 45                  -0.9 (p=0.01)
  Paraphenylenediamin       4                 10                 4                  9                  8                 7                 42                  0.3 (p=0.5)
  PPD mix                   18                1                  12                 3                  6                 1                 41                  -0.6 (p=0.1)
  Thiuram mix               16                3                  1                  6                  9                 4                 39                  -0.4 (p=0.4)
  Ethylenediamine           4                 4                  2                  9                  5                 3                 27                  0.1 (p=0.3)
  Promethazine              2                 6                  2                  6                  3                 3                 22                  -0.3 (p=0.4)
  Formaldehyde              7                 3                  4                  2                  6                 1                 23                  -0.4 (p=0.3)
  Mercaptobenzothiazole     7                 3                  3                  1                  6                 1                 21                  -0.5 (p=0.3)
  Balsam of Peru            2                 0                  3                  8                  1                 3                 17                  0.1 (p=0.7)
  Parabens                  3                 3                  7                  1                  8                 2                 24                  0.9 (p=0.8)
  Hydroquinone              7                 1                  0                  4                  7                 0                 19                  -0.2 (p=0.6)
  Colophony                 4                 1                  3                  5                  3                 1                 17                  -0.9 (p=0.01)
  Lanolin                   4                 3                  3                  5                  1                 1                 17                  -0.3 (p=0.4)
  Quaternium 15             7                 1                  2                  2                  4                 0                 16                  -0.5 (p=0.2)
  Kathon CG                 0                 1                  1                  1                  9                 2                 14                  0.2 (p=0.6)
  Benzocaine                3                 0                  1                  6                  3                 3                 16                  0.5 (p=0.2)
  Nitrofurazone             3                 1                  1                  5                  4                 0                 14                  -0.09 (p=0.8)
  Turpentine                2                 0                  2                  6                  1                 0                 11                  -0.1 (p=0.7)
  Quinoline mix             0                 2                  0                  0                  1                 1                 4                   0.0 (p=1.0)
  Propylene glycol          2                 2                  5                  3                  1                 2                 15                  0.1 (p=0.7)
  Epoxi resin               0                 3                  1                  4                  2                 1                 11                  -0.3 (p=0.4)
  P-tertiary Buthylphenol   2                 0                  1                  0                  1                 1                 5                   -0.3 (p=0.8)
  Irgasan                   1                 1                  0                  0                  3                 0                 5                   0.04 (p=0.4)
  Anthraquinone             1                 1                  1                  1                  0                 0                 4                   -0.8 (p=0.04)
  ------------------------- ----------------- ------------------ ------------------ ------------------ ----------------- ----------------- ------------------- ----------------------------

It is concluded that the standard patch test series was relatively uniform for studied years and only three substances had statistically significant decrease in positivity.

Nevertheless, the number of positive tests for each substance was small, so that the continuation of this investigation might contribute to the evaluation of the main sensitizers in the population studied and also verify which components might be eliminated from the series for presenting ever lower sensitization rates, representing a low risk for ACD.

Study carried out at the Clinica de Dermatologia da Santa casa de São Paulo - São Paulo (SP), Brazil.
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